References
- Alexandrov, P. N., Percy, M. E., & Lukiw, W. J. (2018). Chromosome 21-encoded microRNAS (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease. Cellular and Molecular Neurobiology, 38(3), 769–774. https://doi.org/https://doi.org/10.1007/s10571-017-0514-0
- Azimi, S., Zonouzi, A., Firuzi, O., Iraji, A., Saeedi, M., Mahdavi, M., & Edraki, N. (2017). Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis . European Journal of Medicinal Chemistry, 138, 729–737. https://doi.org/https://doi.org/10.1016/j.ejmech.2017.06.040
- Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016). Dementia in Down syndrome. The Lancet. Neurology, 15(6), 622–636. https://doi.org/https://doi.org/10.1016/S1474-4422(16)00063-6
- Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116(2), 281–297. https://doi.org/https://doi.org/10.1016/s0092-8674(04)00045-5
- Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215–233. https://doi.org/https://doi.org/10.1016/j.cell.2009.01.002
- Brás, A., Rodrigues, A. S., Gomes, B., & Rueff, J. (2018). Down syndrome and microRNAs. Biomedical Reports, 8(1), 11–16. https://doi.org/https://doi.org/10.3892/br.2017.1019
- Castro, P., Zaman, S., & Holland, A. (2017). Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments. Journal of Neurology, 264(4), 804–813. https://doi.org/https://doi.org/10.1007/s00415-016-8308-8
- Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log (N) method for Ewald sums in large systems. Journal of Chemical Physics., 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- Dassault Systèmes BIOVIA (2019). Discovery Studio Modeling Environment; Release 2017. Dessault Systemes. (Original work published 2016).
- Del C Monroig, P., Chen, L., Zhang, S., & Calin, G. A. (2015). Small Molecule Compounds Targeting miRNAs for Cancer Therapy. Advanced Drug Delivery Reviews, 81, 104–116. https://doi.org/https://doi.org/10.1016/j.addr.2014.09.002
- Dexheimer, P. J., & Cochella, L. (2020). MicroRNAs: from mechanism to organism. Frontiers in Cell and Developmental Biology, 8, 409 https://doi.org/https://doi.org/10.3389/fcell.2020.00409
- Faraoni, I., Antonetti, F. R., Cardone, J., & Bonmassar, E. (2009). miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta, 1792(6), 497–505. https://doi.org/https://doi.org/10.1016/j.bbadis.2009.02.013
- Gurjar, A. S., Velingkar, V., Andrisano, V., & Simone, A. G. (2018). Molecular docking, synthesis, in silico and in vitro screening of substituted aryl ureido analogues as bace1 inhibitors to target alzheimer’s disease. Biomed J Sci & Tech Res, 11(4), 8679–8684. https://doi.org/https://doi.org/10.26717/BJSTR.2018.11.002140
- Haghighijoo, Z., Akrami, S., Saeedi, M., Zonouzi, A., Iraji, A., & Larijani, B. (2020). N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer's disease. Bioorganic Chemistry., 103, 104–146. https://doi.org/https://doi.org/10.1016/j.bioorg.2020.104146
- Hong, L., Turner, R. T., Koelsch, G., Shin, D., Ghosh, A. K., & Tang, J. (2002). Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3. Biochemistry, 41(36), 10963–10967. https://doi.org/https://doi.org/10.1021/bi026232n
- Iraji, A., Firuzi, O., Khoshneviszadeh, M., Tavakkoli, M., Mahdavi, M., Nadri, H., Edraki, N., & Miri, R. (2017). Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease. European Journal of Medicinal Chemistry, 141, 690–702. https://doi.org/https://doi.org/10.1016/j.ejmech.2017.09.057
- Jiang, Y., Rigoglioso, A., Peterhoff, C. M., Pawlik, M., Sato, Y., Bleiwas, C., Stavrides, P., Smiley, J. F., Ginsberg, S. D., Mathews, P. M., Levy, E., & Nixon, R. A. (2016). Partial BACE1 reduction in a down syndrome mouse model blocks alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF. Neurobiology of Aging, 39, 90–98. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2015.11.013
- Keck-Wherley, J., Grover, D., Bhattacharyya, S., Xu, X., Holman, D., Lombardini, E. D., Verma, R., Biswas, R., & Galdzicki, Z. (2011). Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to down syndrome phenotypes. Developmental Neuroscience, 33(5), 451–467. https://doi.org/https://doi.org/10.1159/000330884
- Li, Z., & Rana, T. M. (2014). Therapeutic targeting of microRNAs: Current status and future challenges. Nature Reviews. Drug Discovery, 13(8), 622–638. https://doi.org/https://doi.org/10.1038/nrd4359
- Mahernia, S., Hassanzadeh, M., Sarvari, S., & Amanlou, M. (2020). Targeting the microrna binding domain of argonaute 2: Rational inhibitor design and study of mutation effects on protein-ligand interaction. Journal of Biomolecular Structure & Dynamics, 38(16), 4710–4717. https://doi.org/https://doi.org/10.1080/07391102.2019.1688688
- Makarewicz, T., & Kaźmierkiewicz, R. (2013). Molecular dynamics simulation by GROMACS using GUI plugin for PyMOL. ACS Publications.
- Nelson, P. T., & Wang, W. X. (2010). MiR-107 is reduced in Alzheimer’s disease brain neocortex: Validation study. Journal of Alzheimer's Disease, 21(1), 75–79. https://doi.org/https://doi.org/10.3233/JAD-2010-091603
- O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Frontiers in Endocrinology, 9, 402 https://doi.org/https://doi.org/10.3389/fendo.2018.00402
- Rohit, A., Sathisha, K., & Aparna, H. S. (2012). A variant peptide of buffalo colostrum β-lactoglobulin inhibits angiotensin I-converting enzyme activity. European Journal of Medicinal Chemistry, 53, 211–219. https://doi.org/https://doi.org/10.1016/j.ejmech.2012.03.057
- Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., Hatzigeorgiou, A. G., & Antonarakis, S. E. (2007). Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes . American Journal of Human Genetics, 81(2), 405–413. https://doi.org/https://doi.org/10.1086/519979
- Singh, S. K., Bhadra, M. P., Girschick, H. J., & Bhadra, U. (2008). MicroRNAs-micro in size but macro in function. The FEBS Journal, 275(20), 4929–4944. https://doi.org/https://doi.org/10.1111/j.1742-4658.2008.06624.x
- Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247–260. https://doi.org/https://doi.org/10.1016/j.jmgm.2005.12.005
- Wang, W.-X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I., & Nelson, P. T. (2008). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 28(5), 1213–1223. https://doi.org/https://doi.org/10.1523/JNEUROSCI.5065-07.2008
- Wen, D., Danquah, M., Chaudhary, A. K., & Mahato, R. I. (2015). Small molecules targeting microRNA for cancer therapy: promises and obstacles. Journal of Controlled Release : official Journal of the Controlled Release Society, 219, 237–247. https://doi.org/https://doi.org/10.1016/j.jconrel.2015.08.011
- Wiseman, F. K., Pulford, L. J., Barkus, C., Liao, F., Portelius, E., Webb, R., Chávez-Gutiérrez, L., Cleverley, K., Noy, S., Sheppard, O., Collins, T., Powell, C., Sarell, C. J., Rickman, M., Choong, X., Tosh, J. L., Siganporia, C., Whittaker, H. T., Stewart, F., … Fisher, E. M. C, LonDownS Consortium (2018). Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP. Brain : a Journal of Neurology, 141(8), 2457–2474. https://doi.org/https://doi.org/10.1093/brain/awy159
- Zhang, S., Chen, L., Jung, E. J., & Calin, G. A. (2010). Targeting microRNAs with small molecules: From dream to reality. Clinical Pharmacology and Therapeutics, 87(6), 754–758. https://doi.org/https://doi.org/10.1038/clpt.2010.46